Theory Of Drug Design Flashcards
(83 cards)
Describe the principle of dosage form design
Conversion of a new chemical entity NCE into a deliverable medicine.
What is preformulation?
It is the first step in the rational development of dosage forms of a drug into a medicine.
Involves characterising the physical chemical properties of the API that enables us to develop a STABLE and BA dosage form that can be MASS PRODUCED
What is the aim of preformulation?
Produce a model for drug BEHAVIOUR in the proposed dosage form for both IN VITRO/ VIVO
Reduce development costs and time
What is the optimum aqueous solubility of a solid dosage?
> 10mg/ml
What if a drug has sol< 1mg/ml
Salt form of drug if possible
What’s the difference between sol and dissolution rate? Which one is constant?
Sol: the max amount of solute that can be dissolved in given unit of solvent
Diss: the rate of solute can be dissolved to reach that level
Solubility if constant
What are the factors that can affect the diss R?
Noyes Whitney eq DA(Cs-C)/h D. Diffusion coefficient A. Surface area of drug Cs. Solubility (Cmax) C. Concentration in bulk solvent h. Thickness of boundary layer
What is BCS? What type of drug does it apply to?
Biopharmaceutical classification system
Only applicable for oral dosage forms
What are the four classes of BCS? Which characteristic can we modified and which we can’t?
Class I high sol/ permeability Class II low sol/ high perm Class III high sol/ low perm Class IV low/ low Can modify sol not perm
What is Brick dust?
Poorly soluble drugs in aqueous solutions
What do we mean by high risk compounds
Poorly soluble compounds as defined by the FDA biopharmaceutical classification system (II,IV)
Req to enhance BA and dissR
List the methods which can improve dissolution rate and BA in class II IV drugs
Amorphous
Meta stable polymorphs
Solid dispersion
Lipid based formulation (soft liquid gelatin cap)
When do we need to convert a weak acid or base drug into a salt form
When drug has low aqueous solubility
When does the decision on salt form have to be made during development? And why
Decision on a salt form must be made EARLY during PREFORMULATION, preferably BEFORE toxicity testing
Bc A large number of physiochemical properties may change upon formulation of salts
What is the required PKa difference between salt formation and the acid/base?
Delta pka=3
Pros of pharmaceutical salt
Enhance sol Increase dissR Easier synthesis and purification Better taste High BA High melting point -ionic compound Improved photo stability
Cons of pharmaceutical salts
Decrease % of drug Increase hygroscopicity Additional manufacturing steps Increase toxicity Decrease chemical stability No change in sol along GIT (acidic drug suppose to have better sol in SI) Increase no of polymorphs
What is the name of the process of drug salt formation. What are the 2 common used method?
Micro crystallisation
Vapour diffusion
Hanging drop (drug vapour in hanging drop, volatile counterion vapour in reservoir solution, salt formed in the hanging drop)
Sitting drop (drug in a well, react w reservoir via vapour phase)
What are the steps involved in salt selection decision tree?
1) crystallinity (crystalline salt can be prepared)
2) hygroscopicity (salt can’t deliquesce at high humidity)
3) solubility
4) stability
5) polymorphism (final product)
If multiple polymorphs of salt
6) control (to produce desired form)
7) secondary/ final candidate
Story of crack cocaine
Cocaine is bought as a weak base
Does not dissolve in water
IV users use lemon, lime juice or vinegar (acetic acid) to make salt solution for injection
Soluble, hydrophilic salt
What is crystal habit?
The external shape of a crystal. Associated to the way solute molecule orientate themselves when growing.
What factor determines the general shape of crystal?
The growth rate of individual crystal faces
The slowest growing face dominates
Common Types of crystal habit
And what properties they can influence
Tabular
Prismatic
Acicular
Flow
Compatibility
Stability
Solubity
What is miller index (hkl)
Designated index plane of each crystal face. Provides information about the molecular ORDERING of crystal face surface.